Is MC a good stock to buy? We came across a bearish thesis on Moelis & Company on Mispriced Assets’s Substack by Nick Nemeth. In this article, we will summarize the bears’ thesis on MC. Moelis & Company’s share was trading at $68.69 as of April 20th. MC’s trailing and forward P/E were 23.36 and 20.88 respectively according to Yahoo Finance.
Moelis & Company operates as an investment banking advisory company in North and South America, Europe, the Middle East, Asia, and Australia. MC is being viewed through a distinctly bearish lens as concerns mount around an impending downturn in the M&A cycle, which directly drives the firm’s earnings power. The business is highly cyclical and heavily dependent on advisory fees from mergers and acquisitions, making it particularly vulnerable to declines in deal activity.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential
Historically, this sensitivity has been evident, as seen during the 2022–2023 period when revenue fell by approximately 38% in a single year, accompanied by a sharp decline in the stock price of more than 50%. Although the firm eventually recovered, that rebound took multiple years, underscoring the lagging nature of its earnings recovery following downturns.
The current setup suggests a potentially more challenging environment ahead, with expectations that M&A activity could contract meaningfully. Given that Moelis lacks diversification compared to larger, more balanced financial institutions, any slowdown in dealmaking is likely to have an outsized impact on both revenue and profitability. The firm’s reliance on strong deal cycles to sustain performance introduces a structural vulnerability, particularly as macroeconomic uncertainty, higher interest rates, and tighter financing conditions weigh on corporate activity.
Additionally, the firm’s operational intensity and reputation for demanding work environments, while contributing to execution quality, do not offset the broader cyclical risks embedded in its business model. As a result, Moelis appears exposed to a significant earnings reset if deal volumes decline, with limited near-term catalysts to support valuation. This creates a compelling bearish case, where downside risk is amplified by both macro headwinds and inherent business concentration.
Previously, we covered a bullish thesis on JPMorgan Chase & Co. (JPM) by Pacific Northwest Edge in March 2025, which highlighted its dominant position, strong deposit base, capital returns, and resilience across cycles. JPM’s stock price has appreciated by approximately 32.57% since our coverage. Nick Nemeth shares a contrarian view but emphasizes on cyclical risks, weak diversification, and earnings vulnerability in Moelis & Company.
Moelis & Company is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 27 hedge fund portfolios held MC at the end of the fourth quarter which was 24 in the previous quarter. While we acknowledge the risk and potential of MC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than MC and that has 10,000% upside potential, check out our report about this cheapest AI stock.
Disclosure: None.
